Done sou Salè H1B

Akèy › Anplwayè › Vertex Pharmaceuticals Incorporated › Analytical Development Principal Research Associate

Analytical Development Principal Research Associate nan Vertex Pharmaceuticals Incorporated: Salè H-1B

6 aplikasyon kondisyon travay pou tit travay Analytical Development Principal Research Associate nan Vertex Pharmaceuticals Incorporated. Salè baz medyàn ofri $103,060; mwatye mitan $93,796–$107,792.

Demann (LCA)6
Salè medyan ofri$103,060
Mwatye salè yo$93,796–$107,792
10yèm–90yèm pousantaj$91,978–$108,255

Pa ane fiskal

Ane fiskalLCASalè medyan
FY20231$108,410
FY20242$103,676
FY20263$91,978

Aplikasyon

Salè bazKoteSoumètDat kòmansmanEstati
$91,978–$128,500
Nivo II		Boston, MAApr 16, 2026Oct 1, 2026Certifye
$106,870–$123,321
Nivo II		Boston, MAFeb 23, 2026Feb 23, 2026Certifye
$91,978–$128,500
Nivo II		Boston, MAFeb 23, 2026Feb 23, 2026Certifye
$108,100–$124,453Boston, MAJun 25, 2024Dec 6, 2024Certifye
$99,251–$114,138
Nivo II		Boston, MAMar 22, 2024Sep 2, 2024Certifye
$108,410–$124,775
Nivo II		Boston, MAOct 12, 2022Nov 7, 2022Certifye

Lòt travay nan Vertex Pharmaceuticals Incorporated

Salè yo se fen ki pi ba nan salè yo ofri sou chak aplikasyon, konvèti nan yon montan anyèl; estatistik yo itilize sèlman aplikasyon tan plen sètifye. Yon LCA pa yon apwobasyon visa epi yon sèl LCA ka kouvri plizyè pozisyon. Sous: Depatman Travay Etazini, Done Divulgasyon LCA OFLC, ane fiskal 2023–2026 (dènye desizyon Jun 30, 2026).